Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 15, 1998

View Archived Issues

Inex: Q3 1998 highlights

Sanofi-Synthelabo: poised to become number six in Europe

Next-generation SERM presented by Hoechst Marion Roussel

MAA for AcuTect temporarily withdrawn pending submission of additional information

AVI BioPharma reports encouraging clinical data from phase II Avicine study

Procept, Pacific Pharmaceuticals move closer to merger

Medarex reports setback in phase III trial of MDX-RA

Oxigene describes mechanism of action, therapeutic potential of declopramide

U.S. patent issues to Alexion, paving the way to improved xenotransplantation technology

Vanguard Medica takes on development of imiquimod analogue

First launch for Novartis anticoagulant takes place in Germany

Merckle launches new treatment for narcolepsy in Germany

Another market introduction for imiquimod

Anticoagulant cyclic diaza compounds reported by Cor Therapeutics

New antitumor compounds presented by Kyorin

Another merger agreement revealed: Corixa to acquire Anergen

New hemophilia treatment one step closer to market

New prostanoid compound from Ono is a useful tool for studying cardiovascular system

Novel glutamate receptor antagonist shows excellent potential as antiepileptic agent

Review of AIDSVAX studies past and present

Bayer and AxyS initiate development of oral asthma compound

Antipruritic, immunosuppressive MS-444 derivatives reported by Kyowa Hakko

Clinical studies support excellent safety and efficacy of Busulfex

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...